Warberg Asset Management’s Viking Therapeutics, Inc. VKTXW Stock Holding History

Warberg Asset Management’s Portfolio VKTXW Stock Details VKTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-163,536	Closed	-$219K	–	213
2020 Q4	$219K	Buy	+163,536	New	+$746K	0.05%	87

Other funds holding VKTXW

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's VKTXW Position: Q1 2021 in Review

Warberg Asset Management sold out of Viking Therapeutics, Inc. (VKTXW) in Q1 2021, closing a stake of 163,536 shares — an estimated $219K sold.

Warberg Asset Management first reported a position in VKTXW in Q4 2020 and held it in 1 quarter. The position peaked at $219K in Q4 2020. 3 funds tracked by Wall St. Rank hold VKTXW as of Q1 2021.

Warberg Asset Management reported no remaining Viking Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Warberg Asset Management sold 163,536 Viking Therapeutics, Inc. shares in Q1 2021, an estimated $219K.
Warberg Asset Management first reported a position in Viking Therapeutics, Inc. in Q4 2020 and held it in 1 quarter.
Warberg Asset Management's Viking Therapeutics, Inc. position peaked at $219K in Q4 2020.
3 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q1 2021.

Based on Warberg Asset Management's 13F filing for Q1 2021, filed 17 May 2021.